Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs)
Vanta Bioscience Ltd · Outcome · 31 May 2026, 1:55 am
Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 151 (+363.9% YoY | +401.9% QoQ) ■ EBITDA: 139 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 91.6 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 193 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 2.71 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Vanta Bioscience Ltd
- Outcome of Board Meeting · 14 Nov 2026
- Outcome of Board Meeting · 14 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... · 13 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... · 13 Nov 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting · 01 Oct 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizer''s Report for the 10th AGM · 01 Oct 2026
- Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026 · 05 Sept 2026
- Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026 · 31 May 2026
